Carpal Tunnel Syndrome in Athletes: Causes and the Link to Pharmacology
Numb fingers at night, tingling in the thumb and index finger, a weak grip on the bar: carpal tunnel syndrome is usually associated with office work, but it also affects cyclists, climbers, lifters and other athletes. Some cases are linked to medications and performance-enhancing substances that cause fluid retention or tissue growth. Our editorial team reviewed the mechanical and pharmacological causes.
What carpal tunnel syndrome is
The carpal tunnel is a narrow passage in the wrist formed by the wrist bones and a tough band of tissue called the transverse carpal ligament. Nine flexor tendons and the median nerve pass through it. When pressure inside the tunnel rises, the median nerve becomes compressed.
The median nerve supplies sensation to the thumb, index finger, middle finger and part of the ring finger, and it controls some of the small muscles at the base of the thumb. Compression produces numbness, tingling, pain and eventually weakness in this distribution.
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy. A population study by Atroshi and colleagues (1999) estimated that around 3 to 4 percent of adults had clinically confirmed CTS, with symptoms suggestive of it being even more common. Women are affected more often than men.
Anything that takes up space in the tunnel or makes the nerve more vulnerable can contribute. That includes swelling of the tendon sheaths, fluid retention, enlargement of soft tissues, wrist fractures, diabetes, hypothyroidism, pregnancy and rheumatoid arthritis (Padua et al., 2016).
Sport-related risk factors
Repeated or sustained wrist extension under load increases pressure inside the carpal tunnel. Cyclists who lean on the handlebars for hours, gymnasts bearing weight on extended wrists and climbers with strong sustained grips are classic examples.
In strength sports, heavy pressing and front squats with extended wrists, grip-intensive work and high training volumes can irritate the flexor tendons. Wrist wraps used too tightly for too long may also add pressure.
| Sport | Typical mechanism |
|---|---|
| Road and mountain cycling | Prolonged wrist extension and pressure on the palm |
| Rock climbing | Repetitive forceful gripping and finger flexion |
| Weightlifting and powerlifting | Loaded wrist extension, grip volume, tight wraps |
| Wheelchair sports | Repetitive propulsion with wrist loading |
| Racket sports | Repetitive gripping and wrist flexion and extension |
Cyclists can also develop ulnar nerve compression at the wrist, sometimes called handlebar palsy, which causes symptoms in the ring and little fingers instead. Distinguishing the two matters for treatment.
Rapid gains in muscle mass and body weight are associated with CTS in some athletes, possibly through soft-tissue changes in the forearm and wrist. However, this association is less well studied than occupational risk factors.
Medications and substances linked to CTS
Several drugs can provoke or worsen CTS, usually by causing fluid retention or growth of soft tissue. In sport, this is particularly relevant for athletes using growth hormone, insulin-like growth factors or certain hormonal agents without medical supervision.
Growth hormone. Acromegaly, a condition of excess natural growth hormone, is a well-known cause of CTS. In clinical trials, giving recombinant growth hormone to healthy older adults increased the incidence of carpal tunnel syndrome, along with edema and joint pain, as summarized in a systematic review by Liu and colleagues (2007). The same mechanism applies to non-medical use in sport.
Aromatase inhibitors. In breast cancer treatment, aromatase inhibitors such as anastrozole are associated with CTS. An analysis of the ATAC trial by Sestak and colleagues (2009) found a higher incidence of carpal tunnel syndrome with anastrozole than with tamoxifen. Estrogen deprivation may affect tendon sheaths and connective tissue. Non-medical use of these drugs by bodybuilders raises similar concerns, along with risks to bones and lipids.
Other agents. Insulin and diabetes itself are associated with peripheral neuropathy and CTS. Some anabolic steroid users report fluid retention that coincides with nerve symptoms. Oral contraceptives and hormone therapy have been studied as potential contributors, with inconsistent results.
Importantly, CTS caused by drug-related swelling often improves when the cause is removed. This is a reason to tell your doctor about every substance you use, including those obtained without prescription.
Symptoms and diagnosis
Classic symptoms include tingling and numbness in the thumb, index and middle fingers, often worse at night or in the early morning. Many people wake up and shake their hands to relieve the feeling. Symptoms may also appear while gripping handlebars, holding a phone or driving.
- Night-time numbness or tingling in the first three fingers
- Clumsiness or dropping objects
- Weakness of thumb movements and pinch grip
- Visible wasting at the base of the thumb in advanced cases
A doctor usually makes the diagnosis based on history and examination, including provocative tests such as Phalen's maneuver or Tinel's sign. Nerve conduction studies and electromyography confirm the diagnosis and help assess severity. Ultrasound can show nerve enlargement.
Blood tests may be ordered to look for underlying causes, such as diabetes or hypothyroidism. In athletes with unusual features, physicians may also check for hormonal causes, including excess growth hormone.
Treatment and prevention
Mild to moderate CTS often responds to conservative treatment. A neutral wrist splint worn at night is one of the most effective first steps. Activity modification, including adjusting grip and wrist positions in training, reduces irritation.
Corticosteroid injections can provide relief for weeks to months. The American Academy of Orthopaedic Surgeons guideline (Graham et al., 2016) supports splinting and steroid injection as non-surgical options, and surgical release for persistent or severe cases. Surgery, which divides the transverse carpal ligament, has high success rates.
For cyclists, a proper bike fit, padded gloves, changing hand positions frequently and avoiding excessive weight on the hands help. Lifters can use a more neutral wrist position, avoid overly tight wraps and manage grip volume.
When a medication or substance is a likely cause, addressing it with a physician is essential. For those using growth hormone or aromatase inhibitors without medical indication, the safest course is to stop and seek medical evaluation, as CTS can be one of several warning signs of broader harm.
The Editorial Team's Conclusions
Carpal tunnel syndrome in athletes typically results from repetitive or sustained wrist loading, but pharmacology can play an important role.
Growth hormone, aromatase inhibitors and other agents that cause fluid retention or tissue changes can trigger or worsen CTS, and symptoms often improve once the cause is addressed.
Early diagnosis and conservative treatment are usually effective. Persistent weakness or muscle wasting requires prompt medical attention.
Related topics you may find helpful include our articles on growth hormone side effects, on tendon health in lifters, and on safe wrist positioning in pressing movements.
References
- Padua L, Coraci D, Erra C, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016;15(12):1273–1284.
- Atroshi I, Gummesson C, Johnsson R, et al. Prevalence of carpal tunnel syndrome in a general population. JAMA. 1999;282(2):153–158.
- Liu H, Bravata DM, Olkin I, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007;146(2):104–115.
- Sestak I, Sapunar F, Cuzick J. Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial. J Clin Oncol. 2009;27(30):4961–4965.
- Graham B, Peljovich AE, Afra R, et al. The American Academy of Orthopaedic Surgeons evidence-based clinical practice guideline on management of carpal tunnel syndrome. J Bone Joint Surg Am. 2016;98(20):1750–1754.
